CytoSeek uses cell membrane augmentation technology to unlock the potential of next generation of advanced therapies.

They are a spinout company from the University of Bristol. The novel cell membrane augmentation technology enables them to add new functionalities to cell therapies including tissue-specific targeting and enhanced cell survivability.






Word Description


Associated Team Members

Relevant News

Spin out secures £1.1M for ground-breaking ‘supercharged’ cell therapies to treat solid tumours

25 November 2019 A University of Bristol spin-out company has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours…

Read More

CytoSeek Wins at Launch: Great West Rising Star Award

UKI2S would like to congratulate CytoSeek on winning the Rising Star Award at the 1st annual Launch: Great West awards. The Rising Star Award celebrates early stage companies, 3 years…

Read More
Show More